Activation of retinoid X receptors induces apoptosis in HL-60 cell lines
暂无分享,去创建一个
G. Shipley | L. Fésüs | L. Nagy | R. Heyman | V. Thomazy | W. Lamph | R. Chandraratna | P. Davies
[1] R. Chandraratna,et al. Structural basis for the differential RXR & RAR activity of stilbene retinoid analogs , 1994 .
[2] M. Cleary,et al. Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. , 1994, Blood.
[3] D. Mangelsdorf,et al. Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties. , 1994, Journal of medicinal chemistry.
[4] S. Pemrick,et al. The retinoid receptors. , 1994, Leukemia.
[5] S. Collins,et al. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. , 1994, Blood.
[6] J. Pike,et al. Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism. , 1993, The Journal of biological chemistry.
[7] J. Lehmann,et al. Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity. , 1993, Journal of medicinal chemistry.
[8] G. van Zant,et al. Apoptosis and hematopoiesis in murine fetal liver. , 1993, Blood.
[9] J. Lehmann,et al. Retinoids selective for retinoid X receptor response pathways. , 1992, Science.
[10] G. Folkers,et al. A cyclic AMP response element is involved in retinoic acid-dependent RAR beta 2 promoter activation. , 1992, Nucleic acids research.
[11] C. Haslett. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. , 1992, Clinical science.
[12] R. Stockley,et al. The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils. , 1992, The Journal of biological chemistry.
[13] K. Robertson,et al. Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. , 1992, Blood.
[14] K. Robertson,et al. Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells , 1992, Molecular and cellular biology.
[15] J. Lehmann,et al. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid , 1992, Nature.
[16] P. Lemotte,et al. A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] Z. Parandoosh,et al. Interaction of glucocorticoid analogues with the human glucocorticoid receptor , 1992, The Journal of Steroid Biochemistry and Molecular Biology.
[18] D. Green,et al. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. , 1992, Cancer research.
[19] Gregor Eichele,et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.
[20] J. Grippo,et al. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα , 1992, Nature.
[21] M. Pierotti,et al. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. , 1992, Blood.
[22] G. Morriss-Kay. Retinoids in normal development and teratogenesis , 1992 .
[23] L. Fésüs,et al. Apoptosis: molecular mechanisms in programmed cell death. , 1991, European journal of cell biology.
[24] T. Suda,et al. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. , 1991, Blood.
[25] B. Shroot,et al. Selective high affinity retinoic acid receptor alpha or beta-gamma ligands. , 1991, Molecular pharmacology.
[26] K. Umesono,et al. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR , 1991, Cell.
[27] D. van der Helm,et al. Novel heteroarotinoids: synthesis and biological activity. , 1991, Journal of medicinal chemistry.
[28] M. Lanotte,et al. Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate‐kinase I in a myeloid leukemia cell line , 1991, Journal of cellular physiology.
[29] A. Wyllie,et al. Apoptosis: mechanisms and roles in pathology. , 1991, International review of experimental pathology.
[30] J. Spivak,et al. Erythropoietin is both a mitogen and a survival factor. , 1991, Blood.
[31] T. Cotter,et al. Disruption of microtubules induces an endogenous suicide pathway in human leukaemia HL‐60 cells , 1990, Cell and tissue kinetics.
[32] R. Evans,et al. Nuclear receptor that identifies a novel retinoic acid response pathway , 1990, Nature.
[33] S. Collins,et al. Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha) , 1990, Molecular and cellular biology.
[34] M. Koury,et al. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.
[35] T G Cotter,et al. HL‐60 cells induced to differentiate towards neutrophils subsequently die via apoptosis , 1990, Clinical and experimental immunology.
[36] Y. Hashimoto,et al. Expression of retinoic acid receptor genes and the ligand-binding selectivity of retinoic acid receptors (RAR's). , 1990, Biochemical and biophysical research communications.
[37] N. Hogg,et al. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis , 1990, Nature.
[38] K. Sulik,et al. Retinoic-acid-induced limb-reduction defects: perturbation of zones of programmed cell death as a pathogenetic mechanism. , 1989, Teratology.
[39] Y. Hashimoto,et al. Retinobenzoic acids. 3. Structure-activity relationships of retinoidal azobenzene-4-carboxylic acids and stilbene-4-carboxylic acids. , 1989, Journal of medicinal chemistry.
[40] M. Walport,et al. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. , 1989, The Journal of clinical investigation.
[41] A. Dejean,et al. Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes. , 1989, The EMBO journal.
[42] K. Umesono,et al. Retinoic acid and thyroid hormone induce gene expression through a common responsive element , 1988, Nature.
[43] V. Giguère,et al. Identification of a receptor for the morphogen retinoic acid , 1987, Nature.
[44] S. Collins,et al. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. , 1987, Blood.
[45] M. Summers,et al. A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. , 1987 .
[46] M. Sporn,et al. Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. , 1983, Cancer research.
[47] S. Collins,et al. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[48] A. Norman,et al. An hydroxylapatite batch assay for the quantitation of 1alpha,25-dihydroxyvitamin D3-receptor complexes. , 1979, Analytical biochemistry.
[49] S. Collins,et al. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Collins,et al. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture , 1977, Nature.